There is a new drug available for children with uncontrolled asthma caused by airborne allergens.
Xolair is already approved for people, ages 12 and older, with moderate to severe asthma.
It belongs to a class of drugs called biologics. It is given in a doctor’s office by injection. The FDA recently approved it for children between ages 6 and 11 whose asthma is not controlled with other long-term medications.
“Asthma affects more than six million children and is the third leading cause of hospital stays for kids,” said Cary Sennett, MD, PhD, President and CEO of the Asthma and Allergy Foundation of America. “Uncontrolled allergic asthma is a significant burden for these children and their families.”
For more information about this approval, read Genentech's press release: